Nonexomics
2 known investors
NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.
AI & Machine LearningBiotechDeep Tech
Investors · 2
Frequently asked questions
- What does Nonexomics do?
- NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.
- Who are Nonexomics's investors?
- Nonexomics's investors include Illumina Accelerator, Formation Venture Engineering.